Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Qingdao Haier Biomedical Co., Ltd
  6. News
  7. Summary
    688139   CNE100003P25

QINGDAO HAIER BIOMEDICAL CO., LTD

(688139)
  Report
End-of-day quote Shanghai Stock Exchange  -  2023-01-29
76.17 CNY   +0.21%
01/04Tranche Update on Qingdao Haier Biomedical Co., Ltd.'s Equity Buyback Plan announced on February 7, 2022.
CI
2022Beijing residents break free from COVID lockdown
RE
2022Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Nine Months of 2020

10/27/2020 EST

Qingdao Haier Biomedical Co., Ltd. reported earnings results for the nine months of 2020. For the period, basic earnings per share were CNY 0.86.


ę S&P Capital IQ 2020
All news about QINGDAO HAIER BIOMEDICAL CO., LTD
01/04Tranche Update on Qingdao Haier Biomedical Co., Ltd.'s Equity Buyback Plan announced on..
CI
2022Beijing residents break free from COVID lockdown
RE
2022Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Nine Months Ended S..
CI
2022Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Half Year Ended Jun..
CI
2022Basecare Medical and Haier Biomedical Join Forces to Build Cryopreservation Solutions
AQ
2022Suzhou Basecare Signs Strategic Collaboration Framework Deal with Qingdao Haier Biomedi..
MT
2022Tranche Update on Qingdao Haier Biomedical Co., Ltd.'s Equity Buyback Plan announced on..
CI
2022Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended..
CI
2022Tranche Update on Qingdao Haier Biomedical Co., Ltd.'s Equity Buyback Plan announced on..
CI
2022Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended Dec..
CI
More news
Financials
Sales 2022 2 862 M 424 M 424 M
Net income 2022 627 M 92,9 M 92,9 M
Net Debt 2022 - - -
P/E ratio 2022 38,5x
Yield 2022 -
Capitalization 24 161 M 3 580 M 3 580 M
Capi. / Sales 2022 8,44x
Capi. / Sales 2023 6,46x
Nbr of Employees 2 078
Free-Float 48,8%
Chart QINGDAO HAIER BIOMEDICAL CO., LTD
Duration : Period :
Qingdao Haier Biomedical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QINGDAO HAIER BIOMEDICAL CO., LTD
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 76,17 CNY
Average target price 101,79 CNY
Spread / Average Target 33,6%
EPS Revisions
Managers and Directors
Zhan Jie Liu General Manager & Director
Rui Juan Mo Chief Financial Officer
Li Xia Tan Chairman
Xue Juan Zhang Chairman-Supervisory Board
Jiang Tao Zhang Chief Engineer